CAK Determination on Provexa Pharma Kenya Limited v Shalina Healthcare Kenya Limited
Abstract
The Competition Authority of Kenya has approved the proposed acquisition of the entire issued share capital of Provexa Pharma Kenya Limited by Shalina Healthcare Kenya Limited unconditionally.
Publisher
Competition Authority of KenyaCollections
- CAK Determinations [23]